Hyundai ADM Bio Inc. (KOSDAQ:187660)
South Korea · Delayed Price · Currency is KRW 2,870.00
-60.00 (-2.05%)
At close: Jan 29, 2026
Hyundai ADM Bio Market Cap
Hyundai ADM Bio has a market cap or net worth of 157.17 billion as of January 30, 2026. Its market cap has increased by 122.12% in one year.
Market Cap
157.17B
Enterprise Value
160.42B
Revenue
9.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,870.00
Market Cap Chart
Since June 3, 2021, Hyundai ADM Bio's market cap has decreased from 215.74B to 157.17B, a decrease of -27.15%. That is a compound annual growth rate of -6.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 157.17B | 20.59% |
| Dec 30, 2025 | 130.34B | 86.73% |
| Dec 30, 2024 | 69.80B | 57.99% |
| Dec 28, 2023 | 44.18B | 1.39% |
| Dec 29, 2022 | 43.58B | -66.41% |
| Dec 30, 2021 | 129.71B | -39.88% |
| Jun 3, 2021 | 215.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DreamCIS | 149.94B |
| HLB bioStep | 140.56B |
| LabGenomics | 131.33B |
| P&K Skin Research Center | 70.04B |
| C&R Research | 51.72B |
| WOOJUNG BIO | 38.29B |
| DT&CRO CO. | 31.83B |
| SLS BIO | 26.89B |